Skip to main content

What the FDA labels say about taking them together

Clarithromycin and dabigatran

Dabigatran's FDA label of June 25, 2025 names clarithromycin in its drug interactions section; the clarithromycin label PlainMeds reads does not name dabigatran. The dabigatran label: “The use of the P-gp inhibitors verapamil, amiodarone, quinidine, clarithromycin, and ticagrelor does not require a dosage adjustment of PRADAXA.”

Check it at the source: the clarithromycin FDA label on DailyMed (effective April 9, 2026, Solaris Pharma Corporation); the dabigatran FDA label on DailyMed (effective June 25, 2025, Boehringer Ingelheim Pharmaceuticals Inc.).

What does the clarithromycin label say about dabigatran?

Clarithromycin's label (effective April 9, 2026) does not name dabigatran in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Clarithromycin), Solaris Pharma Corporation, effective April 9, 2026 (SPL set 4d42821d-ce7a-7d64-e063-6294a90a0875), via openFDA; the full label on DailyMed

What does the dabigatran label say about clarithromycin?

Dabigatran label, drug interactions

The use of the P-gp inhibitors verapamil, amiodarone, quinidine, clarithromycin, and ticagrelor does not require a dosage adjustment of PRADAXA.

Source: FDA drug label (Pradaxa), Boehringer Ingelheim Pharmaceuticals Inc., effective June 25, 2025 (SPL set ba74e3cd-b06f-4145-b284-5fd6b84ff3c9), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

26Clarithromycin generic labelers
16Dabigatran generic labelers
ClarithromycinDabigatran
Labeled forBacterial infections, Acid reflux and ulcersAtrial fibrillation, Blood clots (DVT and PE), Stroke prevention
Boxed warningNoYes
Pharmacy cost (NADAC)$0.466 per tablet 500 mg tablet$0.795 per capsule 150 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?